AzTrials
AzTrials

Emotional ProblemParentKITNCT05341297

A Transdiagnostic Internet Intervention for Parents of Children With Anxiety and Depressive Symptoms

A study testing ParentKIT in people with Emotional Problem and Anxiety, run by Babes-Bolyai University at 1 site in Romania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the efficacy of a transdiagnostic, parent-led, Internet-delivered intervention in reducing child and adolescent internalizing problems. Read more about this study

Who is it for?
Ages 6 to 14 years
Conditions the study is for
Emotional Problem, Anxiety, Depression
What is being tested?
ParentKIT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
111 participants
Where
1 siteRomania
Study dates
1 Mar 2022to 31 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • parent of a child/ adolescent aged 6 to 14 years
  • elevated internalizing problems
  • have Internet access

Who cannot join

  • undergoing psychotherapy/ pharmacological treatment

Trial locations and contacts

1 site in 1 country.

Romania1 site
  • Babes-Bolyai University

    Cluj-Napoca, 400015

Other trials in Romania

About this study

Official title: Digital Parent-led Transdiagnostic Interventions for Child and Adolescent Anxiety and Depressive Disorders

The purpose of this study is to evaluate the efficacy of a transdiagnostic, parent-led, Internet-delivered intervention in reducing child and adolescent internalizing problems.

Read the detailed description

Anxiety and depressive symptoms are common in children and adolescents. There is substantial research indicating that transdiagnostic Internet interventions are effective for adults and children with anxiety and depressive disorders; however, there is limited research on the efficacy of such programs aimed at parents of children and adolescents with anxiety and depressive symptoms. This study aims to investigate the efficacy of a transdiagnostic Internet intervention for parents of children with elevated anxiety and depressive symptoms.

Being tested
ParentKIT
Keywords
Internet intervention, transdiagnostic, parent-led intervention, internalizing problems, children, Rational emotive and behavioral therapy
Medical subject headings
Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ParentKITBehavioural

    The intervention is structured in 9 modules through which parents learn to identify and manage their children's anxiety and depressive symptoms. The Internet intervention is guided by two psychotherapists under supervision training in Cognitive Behavioral Therapy, trained by the first author on the treatment protocol.

Study groups in NCT05341297
Study groupRoleWhat they receive
ParentKITExperimentalTransdiagnostic parent-led Internet-delivered intervention Participants in the experimental group will have access to the ParentKIT intervention. The intervention was developed based on existing Cognitive Behavioral Therapy/ Rational Emotive Behavior Therapy protocols for parents of children with internalizing problems. It consists of nine modules delivered over three weeks.
Receives: Behavioral: ParentKIT
WaitlistNo interventionParticipants in the waitlist condition will have access to the program after 3 weeks.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the brief Revised Children's Anxiety and Depression Scale - parent version

    Measure of child anxiety and depressive symptoms, as reported by parents. Scores range between 0 and 33; higher scores indicate higher anxiety and depressive symptoms.

    Measured: Baseline, 3 weeks and follow-up at 1 month after treatment termination

Secondary outcomes (4)
  1. Change in the Patient Health Questionnaire-4

    Measure of anxiety and depressive symptoms - will be used to measure changes in parental distress. Scores range between 0 and 12. Higher scores indicate higher distress.

    Measured: Baseline, 3 weeks and follow-up at 1 month after treatment termination

  2. Change in the Parental Self-Efficacy Scale

    Measure of parental self-efficacy in relationship to parenting practices that may decrease anxiety and depression risks for adolescents. Total scores range between and 9 and 36. Higher scores indicate higher parental self-efficacy.

    Measured: Baseline, 3 weeks and follow-up at 1 month after treatment termination

  3. Change in the Family Accommodation Scale

    Measure of parental anxiety accommodations. Scores range between 0 and 52. Higher scores indicate higher parental anxiety accommodations.

    Measured: Baseline, 3 weeks and follow-up at 1 month after treatment termination

  4. Satisfaction with the intervention

    Client satisfaction will be measured with Client Satisfaction Questionnaire, short form (Attkisson \& Zwick, 1982). Scores range from 8 to 32, with higher scores indicating greater satisfaction with the intervention.

    Measured: 3 weeks after treatment initiation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2022
  2. Study start1 Mar 2022
  3. Primary completion30 Jun 2023
  4. Study completion31 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
111 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05341297
Sponsor's protocol ID
GTC 31371/2020
Acronym
ParentKIT
Status last verified
Sep 2023
First submitted
11 Apr 2022
Last updated
13 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data will be uploaded after publication of the results.

Publications

  • Poetar CR, Dobrean A, Andersson G. Preliminary efficacy of a transdiagnostic parent-led internet-delivered intervention for children with anxiety and depressive symptoms: a pilot randomized controlled trial. Child Adolesc Psychiatry Ment Health. 2024 Mar 6;18(1):31. doi: 10.1186/s13034-024-00721-3.

    PubMed 38448874

Questions about this trial

What is this clinical trial studying?

A study testing ParentKIT in people with Emotional Problem and Anxiety, run by Babes-Bolyai University at 1 site in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the brief Revised Children's Anxiety and Depression Scale - parent version (time frame: Baseline, 3 weeks and follow-up at 1 month after treatment termination). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05341297, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in